Fingerprint
Dive into the research topics of 'Randomized study of etirinotecan pegol versus irinotecan as second-line treatment for metastatic colorectal cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Randomized study of etirinotecan pegol versus irinotecan as second-line treatment for metastatic colorectal cancer
Heinz-Josef Lenz, Philip Philip, Mark Saunders, Tatjana Kolevska, Kalyan Mukherjee, Leslie Samuel, Shailesh Bondarde, Tracy Dobbs, Mary Tagliaferri, Ute Hoch, Alison :. Hannah, Maurice Berkowitz
- USC Norris Comprehensive Cancer Center, Los Angeles
- Wayne State University
- The Christie NHS Foundation Trust
- Kaiser Permanente Medical Center, Vallejo
- Chittaranjan National Cancer Institute, Kolkata
- Shatabdi Super Specialty Hospital, Suyojit City Center, Nashik
- Tennessee Cancer Specialists, Knoxville
- Nektar
- Barbara Ann Karmanos Cancer Institute
- Aberdeen Royal Infirmary
- University of California at Los Angeles
Research output: Contribution to journal › Article › peer-review
7
Citations
(Scopus)